48 related articles for article (PubMed ID: 9452363)
1. Dose-dependent activation of p21ras by IFN-beta.
Berger LC; Tamir A; Ben-David Y; Hawley RG
J Interferon Cytokine Res; 1997 Dec; 17(12):757-62. PubMed ID: 9452363
[TBL] [Abstract][Full Text] [Related]
2. S-glutathiolation by peroxynitrite of p21ras at cysteine-118 mediates its direct activation and downstream signaling in endothelial cells.
Clavreul N; Adachi T; Pimental DR; Ido Y; Schöneich C; Cohen RA
FASEB J; 2006 Mar; 20(3):518-20. PubMed ID: 16415107
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor-induced p21ras-mediated signaling is independent of platelet-derived growth factor receptor interaction with GTPase-activating protein or phosphatidylinositol-3-kinase.
Burgering BM; Freed E; van der Voorn L; McCormick F; Bos JL
Cell Growth Differ; 1994 Mar; 5(3):341-7. PubMed ID: 8018566
[TBL] [Abstract][Full Text] [Related]
4. Involvement of p21ras in activation of extracellular signal-regulated kinase 2.
de Vries-Smits AM; Burgering BM; Leevers SJ; Marshall CJ; Bos JL
Nature; 1992 Jun; 357(6379):602-4. PubMed ID: 1608472
[TBL] [Abstract][Full Text] [Related]
5. The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells.
Vitale G; Zappavigna S; Marra M; Dicitore A; Meschini S; Condello M; Arancia G; Castiglioni S; Maroni P; Bendinelli P; Piccoletti R; van Koetsveld PM; Cavagnini F; Budillon A; Abbruzzese A; Hofland LJ; Caraglia M
Biotechnol Adv; 2012; 30(1):169-84. PubMed ID: 21871555
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
Migliaccio A; Di Domenico M; Castoria G; de Falco A; Bontempo P; Nola E; Auricchio F
EMBO J; 1996 Mar; 15(6):1292-300. PubMed ID: 8635462
[TBL] [Abstract][Full Text] [Related]
7. Insulin activates Stat3 independently of p21ras-ERK and PI-3K signal transduction.
Coffer PJ; van Puijenbroek A; Burgering BM; Klop-de Jonge M; Koenderman L; Bos JL; Kruijer W
Oncogene; 1997 Nov; 15(21):2529-39. PubMed ID: 9399641
[TBL] [Abstract][Full Text] [Related]
8. p21ras initiates Rac-1 but not phosphatidyl inositol 3 kinase/PKB, mediated signaling pathways in T lymphocytes.
Genot E; Reif K; Beach S; Kramer I; Cantrell D
Oncogene; 1998 Oct; 17(13):1731-8. PubMed ID: 9796702
[TBL] [Abstract][Full Text] [Related]
9. B cell antigen receptor cross-linking triggers rapid protein kinase C independent activation of p21ras1.
Harwood AE; Cambier JC
J Immunol; 1993 Nov; 151(9):4513-22. PubMed ID: 8409414
[TBL] [Abstract][Full Text] [Related]
10. CD4 ligands inhibit the formation of multifunctional transduction complexes involved in T cell activation.
Jabado N; Pallier A; Le Deist F; Bernard F; Fischer A; Hivroz C
J Immunol; 1997 Jan; 158(1):94-103. PubMed ID: 8977179
[TBL] [Abstract][Full Text] [Related]
11. Fibronectin-induced proliferation in thyroid cells is mediated by alphavbeta3 integrin through Ras/Raf-1/MEK/ERK and calcium/CaMKII signals.
Illario M; Cavallo AL; Monaco S; Di Vito E; Mueller F; Marzano LA; Troncone G; Fenzi G; Rossi G; Vitale M
J Clin Endocrinol Metab; 2005 May; 90(5):2865-73. PubMed ID: 15687337
[TBL] [Abstract][Full Text] [Related]
12. Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells.
Damdinsuren B; Nagano H; Wada H; Kondo M; Ota H; Nakamura M; Noda T; Natsag J; Yamamoto H; Doki Y; Umeshita K; Dono K; Nakamori S; Sakon M; Monden M
Int J Oncol; 2007 Jan; 30(1):201-8. PubMed ID: 17143530
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of B16 melanoma cell proliferation and alterations in p21 ras expression induced by interceptors of signal transduction pathways.
Nordenberg J; Goldwasser I; Zoref-Shani E; Beery E; Sidi Y
Isr J Med Sci; 1996 Dec; 32(12):1153-7. PubMed ID: 9007143
[TBL] [Abstract][Full Text] [Related]
14. Interferon-beta-induced activation of c-Jun NH2-terminal kinase mediates apoptosis through up-regulation of CD95 in CH31 B lymphoma cells.
Takada E; Shimo K; Hata K; Abiake M; Mukai Y; Moriyama M; Heasley L; Mizuguchi J
Exp Cell Res; 2005 Apr; 304(2):518-30. PubMed ID: 15748896
[TBL] [Abstract][Full Text] [Related]
15. Stat1-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand and the cell-surface death signaling pathway by interferon beta in human cancer cells.
Choi EA; Lei H; Maron DJ; Wilson JM; Barsoum J; Fraker DL; El-Deiry WS; Spitz FR
Cancer Res; 2003 Sep; 63(17):5299-307. PubMed ID: 14500361
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of interferon-β on hepatocellular carcinoma HepG2 via Akt/STAT phosphorylation.
Ethiraj P; Veerappan K; Samuel S; Sivapatham S
Fundam Clin Pharmacol; 2015 Jun; 29(3):278-85. PubMed ID: 25773664
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of mitogen-activated protein kinases in a rat model of experimental hepatocellular carcinoma.
McKillop IH; Schmidt CM; Cahill PA; Sitzmann JV
Hepatology; 1997 Dec; 26(6):1484-91. PubMed ID: 9397988
[TBL] [Abstract][Full Text] [Related]
18. The role of p21ras in receptor tyrosine kinase signaling.
Medema RH; Bos JL
Crit Rev Oncog; 1993; 4(6):615-61. PubMed ID: 8286433
[TBL] [Abstract][Full Text] [Related]
19. Sulindac sulfide inhibits Ras signaling.
Herrmann C; Block C; Geisen C; Haas K; Weber C; Winde G; Möröy T; Müller O
Oncogene; 1998 Oct; 17(14):1769-76. PubMed ID: 9778042
[TBL] [Abstract][Full Text] [Related]
20. Interleukin (IL)-2 activation of p21ras in murine myeloid cells transfected with human IL-2 receptor beta chain.
Izquierdo M; Downward J; Otani H; Leonard WJ; Cantrell DA
Eur J Immunol; 1992 Mar; 22(3):817-21. PubMed ID: 1547824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
